This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignees: Syracuse University, Xeragenx LLC. Active years: 2020-2023.
Company Filing History:
2 out of 293 
1 out of 2 Years Active: 2020-2023
Title: Innovations and Contributions of David S. Hermelin
Introduction
David S. Hermelin is an accomplished inventor based in St. Louis, MO. He holds two patents that focus on advancements in glycemic control and peptide stability. His work has significant implications for medical treatments, particularly in managing blood glucose levels.
Latest Patents
Hermelin's latest patents include "Glycemic control using intrinsic factor bound to a vitamin B conjugate of a glucagon-like peptide-1 receptor agonist." This invention provides compositions and methods for lowering blood glucose, specifically through a complex comprising intrinsic factor and a B-conjugated peptide that includes a GLP-1 agonist. The composition can be delivered subcutaneously, offering a practical approach to diabetes management. Another notable patent is "Compositions and methods for enhancing peptide stability against protease digestion." This invention addresses the digestion of peptides by pancreatic proteases and offers methods for protecting against such digestion, enhancing the efficacy of peptide-based treatments.
Career Highlights
Throughout his career, Hermelin has worked with notable institutions, including Syracuse University and Xeragenx LLC. His contributions to the field of medical science have been recognized for their innovative approaches to complex health issues.
Collaborations
Hermelin has collaborated with esteemed colleagues such as Robert Patrick Doyle and Jonathan David Bortz. These partnerships have further enriched his research and development efforts.
Conclusion
David S. Hermelin's work exemplifies the impact of innovation in the medical field. His patents not only advance scientific understanding but also provide practical solutions for managing health conditions. His contributions continue to influence the landscape of medical treatments.